Legionella pneumophila can grow intracellularly in A/J mouse macrophages. 2-Deoxy-D-glucose (2dG) (0.1, 1, and 10 mM) inhibited intracellular multiplication and promoted intracellular killing of L. pneumophila dose dependently when it was added to the culture medium of macrophage monolayers, whereas it did not inhibit the bacterial growth in buffered yeast extract broth, which was used for an L. pneumophila culture. The effect of 2dG was reversible because the surviving bacteria resumed intracellular multiplication after the washing away of 2dG from the culture. The effect of 2dG was also competitively inhibited by high concentrations of glucose. The inhibitory effect of 2dG was not attributed to the inhibition of bacterial phagocytosis by macrophages. Furthermore, sodium fluoride (0.1 and 1 mM), cycloheximide (0.1 and 1 ,ug/ml), and tunicamycin (1, 2, and 5 ,ug/ml) did not promote the killing of L. pneumophila in macrophages, implying that the inhibitory effect of 2dG cannot be attributed to the inhibition of glycolysis, protein synthesis, and protein glycosylation in macrophages. We suggest that 2dG promotes intracellular killing of L. pneumophila by activating some novel killing mechanism of macrophages.
strain difference offers a useful tool for studying the mechanism by which L. pneumophila can or cannot grow intracellularly. We previously studied the genetic control of the differences between strains with regard to the ability of nonactivated mouse macrophages to regulate the intracellular growth of L. pneumophila. We reported that the resistant trait is dominant and that the strain difference is controlled by a gene on chromosome 15 designated Lgn-1 (25) . However, biochemical methods for studying this difference have not yet been performed.
To analyze the mechanism of susceptibility or resistance of mouse macrophages to L. pneumophila, we examined agents which inhibit intracellular bacterial growth in ANJ mouse macrophages with minimal cytotoxicity to macrophages. As a result, we found that 2-deoxy-D-glucose (2dG [a glucose and mannose analog]) inhibited intracellular bacterial proliferation when it was added to the culture medium of the ANJ macrophage monolayer. However, 2dG did not inhibit the growth of L. pneumophila in buffered yeast extract (BYE) broth.
(This study was presented in part at the 4th International Symposium on Legionella, 26 to 29 January 1992, in Orlando, Fla.)
MATERUILS AND METHODS
Bacterium and culture. L. pneumophila Philadelphia-1 was donated by the Centers for Disease Control in 1980. This organism was passaged once in a guinea pig before it was used in this study; i.e., it was inoculated intraperitoneally into a strain Hartley guinea pig and fresh isolates were obtained from the spleen on day 3 postinoculation. These isolates were grown once on buffered charcoal-yeast extractagar plates, which contained a Legionella agar base (Difco Laboratories, Detroit, Mich.) supplemented with (per liter of deionized water) 0.4 g of L-cysteine and 0.25 g of ferric pyrophosphate. The pH was adjusted to 6.9 with 1 M KOH after autoclaving. The bacteria were stored in tryptic soy broth (Difco) supplemented with 30% (vol/vol) glycerol at -80°C. BYE broth was prepared by the method of Ristroph et al. (16) .
Animals. Male A/J mice were obtained from Shizuoka Experimental Animals, Hamamatsu, Japan. These mice were bred in HEPA-filtered racks with laminar flow and were fed laboratory chow and tap water. They were experimented on when they were 8 to 10 weeks old.
Reagents. 2dG (Nakalai Tesque, Kyoto, Japan), sodium fluoride (Wako Pure Chemical Industries, Osaka, Japan), and cycloheximide (Nakalai Tesque) were dissolved in RPMI 1640 medium before use. Tunicamycin (Sigma) was dissolved in 1 M KOH and, after dilution with RPMI 1640 medium, the pH was adjusted to 7.0 with 1 M HCl. Glucosefree RPMI 1640 medium was purchased from Sigma, and 15 mM glucose was added before use. broth. The bacteria were grown in BYE broth without 2dG (-) or with 1 (0) or 10 (A) mM 2dG. They were also cultured in RPMI 1640 medium containing 10% newborn calf serum, which was used for the macrophage culture (E), or were cultured in the medium obtained after a 24-h culture of A/J macrophages after filtration (-).
10 mM) had no inhibitory effects on bacterial growth (Fig. 1) . The bacteria could not grow in the RPMI 1640 medium supplemented with 10% newborn calf serum which was used for macrophage culture, nor could bacteria grow in the culture medium obtained after a 24-h culture of macrophages.
Effect of 2dG on the intracellular growth of L. pneumophila in A/J macrophages. Because incubation of macrophages in glucose-free RPMI medium containing 2dG (1 and 10 mM) caused cellular damage, we used a medium after 15 mM glucose had been added. Without 2dG, L. pneumophila grew in A/J macrophages approximately 10-fold during a 24-h period ( Fig. 2A) . When 2dG was added to the culture medium after 4 h of phagocytosis, the intracellular bacterial growth thereafter was inhibited dose dependently ( Fig. 2A) . Figure 2B shows the sum of numbers of bacteria in macrophage monolayers and in the culture media. The inhibitory effect of 2dG was again noted, which proves that a decrease in numbers of bacteria in the 2dG-treated macrophages of Fig. 2A is not due to the detachment of macrophages. Macrophage viability was tested by the trypan blue exclusion method. When macrophages were exposed to 2dG for 24 h, macrophage viability was well maintained, at approximately 95% in 1 mM 2dG and 90% in 10 mM 2dG; after a 48-h culture, viability decreased to 80 and 50%, respectively. Nevertheless, the number of intracellular CFU of L. pneumophila continued to decrease during 24 to 48 h of culture (Fig. 2B ). An addition of 1 or 10 mM 2dG after 18 h of culture also inhibited bacterial multiplication and promoted the killing thereafter (data not shown). These with RPMI 1640 medium with 10% newborn calf serum, bacterial growth started again (Fig. 3) .
Effect of high concentrations of glucose on the effects of 2dG. As described, 1 mM 2dG inhibited intracellular bacterial growth in macrophages cultured in the RPMI 1640 medium supplemented with 15 mM glucose. The capacity of glucose to reverse the inhibitory effect of 2dG was examined. When the glucose concentration was increased to 30 or 60 mM after 8 recovered and the bacteria resumed intracellular growth (Fig. 4) .
Effects of sodium fluoride, cycloheximide, and tunicamycin on the intracellular growth of L. pneumophila. It has been demonstrated that 2dG interferes with glycolysis, protein synthesis, and protein glycosylation (17) . We examined whether some metabolic inhibitors can mimic the effects of 2dG. Sodium fluoride (a glycolysis inhibitor [0.1, 1, and 5 mM]), cycloheximide (a protein synthesis inhibitor [0.1, 1, and 5 ,ug/ml]), or tunicamycin (an N-glycosylation inhibitor [1, 2, and 5 ,ug/ml]) was added to the culture. As shown in Fig. 5 , sodium fluoride (0.1, and 1 mM) and tunicamycin (1, 2, and 5 ,ug/ml) had no effect on the growth of L. pneumophila in macrophages. Cycloheximide (0.1 and 1 ,ug/ml) inhibited intracellular bacterial growth to some extent, but it did not kill the intracellular bacteria. Because 5 mM sodium fluoride and 5 ,ug of cycloheximide per ml were toxic to macrophages, the data are not shown in the figures. The growth of L. pneumophila in BYE broth was negligibly affected by adding the same concentrations of these reagents (data not shown). DISCUSSION 2dG inhibited the intracellular multiplication and promoted the intracellular killing of L. pneumophila in A/J mouse macrophages when it was added to the culture media of macrophage monolayers. 2dG did not have a direct inhibitory effect on bacterial growth because it could not inhibit bacterial growth in BYE broth (Fig. 1) . This result is compatible with data showing that L. pneumophila does not utilize sugars, including glucose (19) .
2dG is known as an inhibitor of glucose metabolism that inhibits the glycolytic pathway. It blocks the conversion of glucose 6-phosphate to fructose-6-phosphate because 2-deoxy-glucose 6-phosphate cannot be utilized as a substrate of glucose 6-phosphate isomerase in the glycolytic pathway (20) . In general, mononuclear phagocytes derive the bulk of their metabolic energy from glucose oxidation, resulting in production of pyruvate and lactate (10) .
It has been reported that 2dG inhibits the following functions of mouse macrophages: (i) complement-or Fcmediated phagocytosis (11, 17) , (ii) ATP synthesis (12), (iii) protein synthesis (17) , and (iv) protein glycosylation (17) . Our work was carried out carefully to elucidate that the inhibitory effect of 2dG on intracellular bacterial growth was not attributable to inhibition of phagocytosis. After 1.5 h of in vitro phagocytosis, nonphagocytosed bacteria were removed by washing. Macrophage monolayers were cultured additionally for 2.5 h to accomplish the phagocytosis, and thereafter 2dG was added to the culture medium. Besides, the inhibitory effect of 2dG may not be due to the inhibition of continuous reinfection by the bacteria which were released from the infected and eventually killed macrophages, because the effect of 2dG was observed 12 h after the onset of phagocytosis, when release of bacteria from macrophages hardly takes place.
It has been reported that 2dG causes a decrease in cellular ATP levels in thioglycolate-elicited macrophages (12) . However, the finding that 2dG blocks bacterial growth at 1 mM in the medium containing 15 mM glucose suggests that this is not a result of ATP depletion. 2dG (1 mM) in the presence of 15 mM glucose will have only a slight effect on the cellular ATP level. The other glycolytic inhibitor, sodium fluoride, was tested in our system. The results, that 0.1 and 1 mM NaF did not suppress intracellular bacterial growth, also support the assumption that the effect of 2dG is not merely due to the inhibition of glycolysis. The inhibitory effect of 2dG may not be due to the inhibition of protein synthesis or glycosylation, because cycloheximide or tunicamycin could not inhibit intracellular bacterial growth (Fig. 5) (5) . Electron microscopic examination revealed that a similar mechanism was working in A/J mouse macrophages (21) . We also observed similar events in A/J mouse and guinea pig macrophages that permitted intracellular bacterial growth (unpublished observation). This complex series of cytoplasmic events is assumed to be a supporting system for the intracellular growth of L. pneumophila. We propose that the characteristic phagosome be called a "legionellaphorous vacuole" after the "parasitephorous vacuoles" which are formed in macrophages during Leishmania infection (18) .
There remains the question of whether 2dG directly interfered with the formation of legionellaphorous vacuoles or whether it augmented the bacterial killing and consequently suppressed the appearance of the supporting system. At first, we thought that 2dG inhibited the appearance of legionellaphorous vacuoles, but the effect of 2dG of accelerating intracellular killing was observed in macrophages of C57BL/6 mice in which the supporting system was not induced (data not shown). This result implies that promotion of intracellular killing consequently suppressed the appearance of the supporting system in A/J macrophages. Morphological study of the intracellular killing is currently under way by electron microscopy.
The first aim of our work was to analyze biochemically the differences between strains in terms of the susceptibility or resistance of mouse macrophages to L. pneumophila. From the results obtained, it is very improbable that the difference between mouse strains is related to the effect of 2dG.
VOL. 62, 1994 on August 28, 2017 by guest http://iai.asm.org/
Downloaded from
Horwitz and Silverstein reported that rifampin and erythromycin were only bacteriostatic for Legionella organisms growing in human macrophages (9) , and Byrd and Horwitz showed that gamma interferon-treated macrophages blocked Legionella growth but did not kill the bacterium (2). Thus, this study gives the first indication that an antimetabolite can kill L. pneumophila intracellularly in macrophages. It is difficult to say specifically how 2dG eradicates intracellular bacteria, but further study may identify novel mechanisms that kill intracellular bacteria or may identify lethal changes in the metabolism of intracellular Legionella organisms.
